Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
9 Tammi 20127min
Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma
Interview with Patricia Chévez-Barrios, MD, author of Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma
14 Marras 201110min
